Speaker illustration

Mr Stavros Stavrakis

University of Oklahoma, Oklahoma City (United States of America)

Member of:

European Society of Cardiology

Dr. Stavrakis is a clinical electrophysiologist and physician scientist at the University of Oklahoma. He is an Associate Professor of Medicine and the Director of Cardiovascular Research. Having trained and worked with one of the fathers of Electrophysiology, Dr. Jackman, he has been routinely performing complex ablations for the last 10 years. His research has focused on autonomic modulation for the treatment of atrial fibrillation and heart failure, in both animal models and in humans. His work over the last 10 years culminated in a first-in-human randomized clinical trial, examining the chronic effect of noninvasive vagus nerve stimulation in patients with paroxysmal atrial fibrillation, which was presented as a late breaking trial at the Heart Rhythm Society Scientific Sessions in May 2019. His goal is to continue to explore the role of the autonomic nervous system in cardiac arrhythmias and provide his expertise in both clinical procedures and research activities.

Screening for Atrial Fibrillation in Native Americans using iPhone ECG

Event: ESC Congress 2019

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Early detection of Atrial Fibrillation


Sex differences in rats with heart failure with preserved ejection fraction and the effect of autonomic modulation

Event: ESC Congress 2019

Topic: Experimental Heart Failure

Session: Sex differences in heart failure


Transcutaneous vagus nerve stimulation attenuates cardiac remodeling in a rat model of heart failure with preserved ejection fraction

Event: ESC Congress 2018

Topic: Devices for Autonomic Modulation

Session: Chronic heart failure – Treatment


Low level transcutaneous vagus nerve stimulation acutely ameliorates diastolic function in humans

Event: ESC Congress 2017

Topic: Diastolic dysfunction

Session: Chronic heart failure (CHF)


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb